SMCBF yields 2046.77% · PFE yields 6.13%● Live data
📍 SMCBF pulled ahead of the other in Year 1
Combined, SMCBF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SMCBF + PFE for your $10,000?
The Siam Commercial Bank Public Company Limited provides various financial products and services. The company offers various personal banking products and services, including savings, current, fixed deposit, and long term deposit accounts; payroll solutions; home, car, and personal loans; accident, savings, health expense, and other insurance services; debit, credit, prepaid, and gift cards; mutual funds, bonds, debentures, and other investment products; and payment, digital banking, and other services. It also provides corporate banking products and services comprising credit facilities; financial advisory and merger acquisition services; fixed income instrument and underwriting, structured finance, and project finance services; foreign exchange rate risk management, interest rate risk management, and investment solutions; cash management services; custodian, mutual fund supervisory, registrar, escrow and security agency, debenture's holder representative, and custodian net services; and international trade remittance and digital banking services. In addition, the company engages in the office spaces leasing, hire-purchase, vehicle lending and leasing, and research and development businesses. Further, it provides debt collection services; and food ordering platform and other technological solutions. The company provides its products and services through its head office and branch network in Thailand; and through its branches in Singapore, Hong Kong, Laos, Vietnam, China, and the Cayman Islands. The company is headquartered in Bangkok, Thailand.
Full SMCBF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.